Divi's Laboratories Limited Max Pain Analysis
What is Max Pain?
Max Pain theory states the underlying gravitates toward the strike where option writers face minimum collective loss at expiry. For DIVISLAB, that strike is ₹6,100. Spot at ₹6,252 is 2.49% above max pain — possible downward gravitational pull into expiry.
Max Pain Level
The maximum pain strike for Divi's Laboratories Limited is ₹6100, where option sellers experience minimal assignment risk. This level acts as a magnet ahead of expiry, as price tends to gravitate toward the strike with the least cost to writers.
Spot vs Max Pain Gap
The spot price at ₹6252 sits 2.49% above the max pain level, creating an upward gap. This premium suggests potential downward pressure as market forces may pull the spot toward ₹6100 to reduce open option value.
Shift Signal
The max pain has held steady at ₹6100, showing no shift from the previous day. Stable pain levels indicate that writer positioning remains anchored, with concentrated short options at ₹6100 and nearby ₹6050.
Expiry Bias
With 7 days to expiry, a gradual drift toward ₹6100 is expected, aligning spot with minimal aggregate pain. However, the pull strengthens meaningfully only if the trend accelerates inside the final five days.
Trader Note
With more than 5 days until expiry, focus on premium decay strategies only if time decay accelerates and spot approaches the ₹6050–₹6100 zone.
Data as of 2026-04-21